Human Genome Epidemiology Literature Finder
|
Records 1 - 3 (of 3 Records) |
| Query Trace: Neuroblastoma and FCGR2A[original query] |
|---|
| FCGR2A polymorphism is correlated with clinical outcome after immunotherapy of neuroblastoma with anti-GD2 antibody and granulocyte macrophage colony-stimulating factor. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006 Jun 24 (18): 2885-90. Cheung Nai-Kong V, Sowers Rebecca, Vickers Andrew J, Cheung Irene Y, Kushner Brian H, Gorlick Richa |
| Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin. Oncotarget 2015 Nov . Kushner Brian H, Ostrovnaya Irina, Cheung Irene Y, Kuk Deborah, Modak Shakeel, Kramer Kim, Roberts Stephen S, Basu Ellen M, Yataghene Karima, Cheung Nai-Kong |
| Neuroblastoma patients with high-affinity FCGR2A, -3A and stimulatory KIR 2DS2 treated by long-term infusion of anti-GD antibody ch14.18/CHO show higher ADCC levels and improved event-free survival. Oncoimmunology 2016 5 (11): e1235108. Siebert Nikolai, Jensen Christian, Troschke-Meurer Sascha, Zumpe Maxi, Jüttner Madlen, Ehlert Karoline, Kietz Silke, Müller Ina, Lode Holger |
- Page last reviewed:Feb 1, 2024
- Content source: